Sugi Predict

Sugi Predict / Targets / DOCK11

DOCK11

Dedicator of cytokinesis protein 11 · Q5JSL3 · DOCK11 on Sugi Atlas →

0 patent compounds predicted against DOCK11, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DOCK11 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency PHASE2ACTIVE_NOT_RECRUITING
Better Delineation of BCL11B Related Phenotype and Epigenetic Signature. nanCOMPLETED
Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer nanUNKNOWN
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms nanUNKNOWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Chromosome 9 P Minus Syndrome nanRECRUITING
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions nanCOMPLETED
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Clinical Genetics Branch Eligibility Screening Survey nanNOT_YET_RECRUITING
PCD New Gene Discovery nanCOMPLETED
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia nanUNKNOWN
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial nanRECRUITING
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants nanRECRUITING
Using Next-generation Sequencing in the Diagnosis of Epilepsy and/or Intellectual Disability in a Pediatric Cohorte nanCOMPLETED
The Clinical Study of Sex Chromosome Variants nanCOMPLETED
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies nanRECRUITING
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature. nanUNKNOWN
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy nanCOMPLETED
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome nanRECRUITING
Second Molecular Event Identification by Exome Sequencing for Intellectually Disabled Patients Carrying 16p13.11 CNVs nanUNKNOWN
Speech and Short-term Memory Functions in Dyslexia: a Combined MEG and EEG Study nanUNKNOWN
Angelman Syndrome Natural History Study nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a DOCK11 binder may also engage these)

ProteinNameSimilarity
A2AF47 — 1.000 A2AF47 →
Q96BY6 — 1.000 Q96BY6 →
B0R034 — 1.000 B0R034 →
Q8BZN6 — 1.000 Q8BZN6 →
Q96N67 — 0.994 Q96N67 →
Q80TJ1 — 0.991 Q80TJ1 →
Q95JW3 — 0.991 Q95JW3 →
Q6AZT6 — 0.991 Q6AZT6 →
Q86UW7 — 0.991 Q86UW7 →
Q6GLR7 — 0.991 Q6GLR7 →
Q8NF50 — 0.990 Q8NF50 →
Q62717 — 0.990 Q62717 →
Q8BYR5 — 0.990 Q8BYR5 →
Q5R8B7 — 0.990 Q5R8B7 →
Q8IZC4 — 0.989 Q8IZC4 →
Q7Z392 — 0.989 Q7Z392 →
P37199 — 0.989 P37199 →
Q8C147 — 0.989 Q8C147 →
O15259 — 0.989 O15259 →
Q9ULU8 — 0.989 Q9ULU8 →
O02697 — 0.989 O02697 →
Q14B46 — 0.989 Q14B46 →
O94915 — 0.989 O94915 →
Q91WS7 — 0.988 Q91WS7 →
Q4QR86 — 0.988 Q4QR86 →
Q2TAF4 — 0.988 Q2TAF4 →
P42228 — 0.988 P42228 →
Q8BMG7 — 0.988 Q8BMG7 →
Q8R1A4 — 0.988 Q8R1A4 →
B0DOB4 — 0.987 B0DOB4 →